Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece

Personalized Medicine

Volumn 11, Issue 1, 2014, Pages 15-26

  Mai, Yuan ^a   Mitropoulou, Christina ^a   Papadopoulou, Xanthi E ^a   Vozikis, Athanassios ^c   Cooper, David N ^d   Van Schaik, Ron H ^b   Patrinos, George P ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF PIRAEUS   (Greece)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

genetics education; healthcare professionals; pharmacists; pharmacogenomics; physicians; public health genomics

Indexed keywords

EID: 84893875265     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.13.92     Document Type: Article

References (27)

1. Chen JM, Férec C, Cooper DN. Revealing the human mutome. Clin. Genet. 78(4), 310-320 (2010).
2. Cooper DN, Chen JM, Ball EV et al. Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics. Hum. Mutat. 31(6), 631-655 (2010).
3. Guttmacher AE, McGuire AL, Ponder B, Stefánsson K. Personalized genomic information: preparing for the future of genetic medicine. Nat. Rev. Genet. 11(2), 161-165 (2010).
4. Ginsburg GS, Willard HF. Genomic and personalized medicine: foundations and applications. Transl. Res. 154(6), 277-287 (2009).
5. Phillips KA, van Bebber SL. A systematic review of cost-effectiveness analyses of pharmacogenomic interventions. Pharmacogenomics 5(8), 1139-1149 (2004). (Pubitemid 40045254)
6. Hietala M, Hakonen A, Aro AR, Niemelä P, Peltonen L, Aula P. Attitudes toward genetic testing among the general population and relatives of patients with a severe genetic disease: a survey from Finland. Am. J. Hum. Genet. 56(6), 1493-1500 (1995).
7. Balck F, Berth H, Meyer W. Attitudes toward genetic testing in a German population. Genet. Test. Mol. Biomarkers 13(6), 743-750 (2009).
8. Makeeva OA, Markova VV, Roses AD, Puzyrev VP. An epidemiologic-based survey of public attitudes towards predictive genetic testing in Russia. Per. Med. 7(3), 291-300 (2010).
9. National Institutes of Health, Office of Science Policy, Office of Biotechnology Activities. http://oba.od.nih.gov/SACGHS/sacghs-home.html
10. Mai Y, Koromila K, Sagia A et al. A critical view of the general public's awareness and physicians' opinion of the trends and potential pitfalls of genetic testing in Greece. Per. Med. 8(5), 551-561 (2011).
11. Pavlidis C, Karamitri A, Barakou A et al. Ascertainment and critical assessment of the views of the general public and healthcare professionals on nutrigenomics in Greece. Per. Med. 9(2), 201-210 (2012).
12. Sagia A, Cooper DN, Poulas K, Stathakopoulos V, Patrinos GP. A critical appraisal of the private genetic and pharmacogenomic testing environment in Greece. Per. Med. 8(4), 413-420 (2011).
13. Metzker ML. Sequencing technologies-the next generation. Nat. Rev. Genet. 11(1), 31-46 (2010).
14. Patrinos GP, Baker D, Mulla F Al, Vasiliou V, Cooper DN. Genetic test obtainable through pharmacies: the good, the bad and the ugly. Hum. Genomics 7, 17 (2013).
15. Reydon TA, Kampourakis K, Patrinos GP. Genetics, genomics and society: the responsibilities of scientists for science communication and education. Per. Med. 9(6), 633-643 (2012).
16. Singer E, Couper MP, Raghunathan TE, van Hoewyk J, Antonucci TC. Trends in US attitudes toward genetic testing. Public Opin. Q. 72(3), 446-458 (2008).
17. Kimberly J. Pharmacogenetics and the Pharmacy Profession: A Sociological Exploration. Thesis, University of York, York, UK (2012).
18. McCullough KB, Formea CM, Berg KD et al. Assessment of the pharmacogenomics educational needs of pharmacists. Am. J. Pharm. Educ. 75(3), 51 (2011).
19. Higgs JE, Andrews J, Gurwitz D, Payne K, Newman W. Pharmacogenetics education in British medical schools. Genomic Med. 2(3-4), 101-105 (2008).
20. Lee KC, Ma JD, Hudmon KS, Kuo GM. A train-the-trainer approach to a shared pharmacogenomics curriculum for US colleges and schools of pharmacy. Am. J. Pharm. Educ. 76(10), 193 (2012).
21. de Denus S, Letarte N, Hurlimann T et al. An evaluation of pharmacists' expectations towards pharmacogenomics. Pharmacogenomics 14(2), 165-175 (2013).
22. Stanek EJ, Sanders CL, Taber KA et al. Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey. Clin. Pharmacol. Ther. 91(3), 450-458 (2012).
23. Haga SB, Burke W, Ginsburg GS, Mills R, Agans R. Primary care physicians' knowledge of and experience with pharmacogenetic testing. Clin. Genet. 82(4), 388-394 (2012).
24. Kricka LJ, Fortina P, Mai Y, Patrinos GP. Direct-access genetic testing: the view from Europe. Nat. Rev. Genet. 12(10), 670 (2011).
25. Howard HC, Borry P. Direct-to-consumer pharmacogenomic testing. Pharmacogenomics 12(10), 367-1370 (2011).
26. Patrinos GP, Baker DJ, Al-Mulla F, Vasiliou V, Cooper DN. Genetic tests obtainable through pharmacies: the good, the bad, and the ugly. Hum. Genomics doi:10.1186/1479-7364-7-17 (2013).
27. American Pharmacists Association. Integrating pharmacogenomics into pharmacy practice via medication therapy management. J. Am. Pharm. Assoc. 51, e64-e74 (2011).